Friday, October 09, 2009

GSK - Pandemrix: it's an ill wind

Analysts are predicting UK pharma giant GlaxoSmithKline will be hitting a £3 billion jackpot by the end of the year following demand for its swine flu vaccine Pandemrix.

Orders for the jab, which begin shipments this week, have jumped since August with an additional 22 government orders to supply a further 149 million doses of the vaccine. The total number of doses now ordered comes to 440 million.

No comments: